Constellation Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $940K | Buy |
11,825
+225
| +2% | +$17.9K | 0.17% | 127 |
|
|
2015
Q4 | $1.46M | Buy |
11,600
+175
| +2% | +$22K | 0.27% | 81 |
|
|
2015
Q3 | $1.19M | Buy |
11,425
+150
| +1% | +$15.6K | 0.25% | 88 |
|
|
2015
Q2 | $1.39M | Buy |
11,275
+175
| +2% | +$21.6K | 0.27% | 85 |
|
|
2015
Q1 | $1.31M | Buy |
11,100
+325
| +3% | +$38.3K | 0.25% | 89 |
|
|
2014
Q4 | $1.28M | Buy |
10,775
+475
| +5% | +$56.4K | 0.26% | 88 |
|
|
2014
Q3 | $1.16M | Buy |
10,300
+125
| +1% | +$14K | 0.26% | 89 |
|
|
2014
Q2 | $963K | Sell |
10,175
-50
| -0.5% | -$4.73K | 0.22% | 105 |
|
|
2014
Q1 | $723K | Buy |
10,225
+525
| +5% | +$37.1K | 0.18% | 133 |
|
|
2013
Q4 | $721K | Buy |
9,700
+650
| +7% | +$48.3K | 0.18% | 127 |
|
|
2013
Q3 | $686K | Buy |
9,050
+4,575
| +102% | +$347K | 0.21% | 111 |
|
|
2013
Q2 | $357K | Buy |
+4,475
| New | +$357K | 0.12% | 194 |
|